First myocardial infarction in a Dutch general practice population: trends in incidence from 1975-2003

Carel Bakx1, Judith Schwarte, Henk van den Hoogen

  • 1Department of Family Medicine, University Medical Centre, Nijmegen, The Netherlands. C.Bakx@hag.umcn.nl

Insights

The incidence of first myocardial infarctions has declined since 1986, particularly in men, suggesting primary prevention efforts may be effective. This study tracked first-time heart attacks in a general practice population.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Morbidity registrations often do not differentiate between first and subsequent myocardial infarctions (MIs).
  • The extent to which falling MI rates are due to lower first MI incidences remains unclear.

Purpose of the Study:

  • To investigate the incidence of first myocardial infarctions (MIs) within a general practice population.
  • To analyze trends in first MI incidence and related mortality.

Main Methods:

  • Utilized data from the Continuous Morbidity Registration (CMR) Nijmegen (1975-2003).
  • Calculated sex-specific and age-specific yearly incidence rates.
  • Employed Poisson regression to analyze trends in first MI incidence.

Main Results:

  • Identified 827 first myocardial infarctions (MIs) during the study period.
  • First MI incidence declined since 1986 to 2.1/1000 (men) and 1.5/1000 (women).
  • Sudden cardiac death from first MI significantly decreased since 1986.

Conclusions:

  • A significant decline in first myocardial infarction (MI) incidence was observed, more pronounced in men.
  • A mean annual decline of 3.5% in first MI deaths since the mid-1980s suggests potential primary prevention impact.
  • The average age for a first MI increased in men, indicating a shift in risk factors or protective effects.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...